Imaver: Empowering Lives Affected by Chronic Myeloid Leukemia
Imaver is a breakthrough oncology drug specifically designed to treat adult and pediatric patients diagnosed with chronic myeloid leukemia (CML) carrying the Philadelphia chromosome mutation (Ph+). With its targeted mechanism of action, Imaver aims to disrupt the growth of cancer cells, offering new hope for patients and their families.
Indication
Who Should Avoid Taking IMAVER
Safety Information
Please see full Prescribing Information, which includes a more complete discussion of the risks associated with IMAVER.
